By definition, complex traits such as obesity and its comorbidities result from complex origins. At the very least these include genetic, environmental and behavioral causes and their interactions. Epidemiological-based studies have identified some well-known, replicated, environmental and genetic risk factors for complex diseases. However, at the population level, investigations have tended to focus on a single cause, rarely combining a multidisciplinary approach.

Regarding genetics, genome-wide association studies (GWAS) have been one tool that genetic epidemiologists have used to identify genetic variation contributing to disease risk. GWAS have tended to be criticized for identifying associated markers but not functional mutations, for potentially missing important genetic variation by overlooking minorities, and especially for explaining only a small proportion of the heritability of a trait. However, GWAS are designed to be somewhat hypothesis-generating, and despite the criticisms, many associations identified to date provide leads for additional studies ([@bb0020]). One well-studied and replicated set of GWAS results focuses on the region of chromosome 9 (9p21.3) which encodes cell cycle-regulating products of the cyclin-dependent kinase inhibitor 2A/B (*CDKN2A/B*) locus, including the long non-coding RNA ANRIL (antisense noncoding RNA in the INK4 locus). This locus has been associated with many diseases including coronary artery disease, atherosclerosis, type 2 diabetes and cancer. However, despite extensive studies to date, it is not clear how this locus acts to impact disease ([@bb0010]), nor how behavior and environment might mitigate these effects.

Epidemiologists have also investigated behavioral and environmental influences such as nutrition on development of disease. Dr. David Barker was one of the first investigators to report an observed link between prenatal undernutrition and later heart disease, hypothesizing that it resulted from an affluent diet as an adult ([@bb0005]). Since his initial study, there has been additional investigation and debate surrounding this hypothesized link, leading to a continuing refinement of a fetal origins of adult diseases hypothesis. Notwithstanding, the evidence is overwhelming that prenatal exposures can impact adult traits. The biological mechanisms underlying these population-level associations have yet to be determined. One suggestion supported by experimental evidence is that epigenetic mechanisms might translate early life exposures into changes, such as altered gene expression, that persist throughout the life course, and possibly beyond to future generations. It has recently become possible to assess epigenetic markers such as DNA methylation on a large scale, allowing population-based studies to include epigenetic modifications as biomarkers in studies of complex traits.

In this issue, [@bb0015] provide a link between these results. The investigators measured genome-wide DNA methylation patterns during the perinatal period (from umbilical cord blood) and assessed their association with adiposity in childhood using a cohort from the Southampton Women\'s Survey. They identified 93 differentially methylated regions (DMRs) associating with percent fat mass at six years of age. Interestingly, one DMR was located near the *CDKN2A* locus, with lower methylation of the *CDKN2A* DMR at birth associated with higher percent fat mass at age 4 and 6 years. Given the well-known GWAS results pertaining to this locus, they focused follow-up analyses on this region. They replicated their results in three other cohorts including another sample of umbilical cord DNA from infants, in DNA isolated from peripheral blood samples in adolescents, and in DNA from subcutaneous adipose tissue in adults. They moved towards further understanding of their association findings by showing that methylation levels in this DMR affect the levels of expression of transcripts from this locus (ANRIL, p16^INK4a^ and p14^ARF^). Finally, they demonstrated effects on ANRIL and p14^ARF^ promoter activity and transcription factor binding in the DMR.

This study\'s novelty is that prior to it, there was no evidence bringing together the fetal origins of adult disease hypothesis with the epigenetic regulation of transcript expression at the *CDKN2A/B* locus. This study broadens the cardio-metabolic impact of the *CDKN2A/B* locus, and in addition provides initial mechanistic evidence of how the epigenetic state in the perinatal period might affect later adiposity. The study raises many subsequent questions for future investigations including what causes differential methylation at this locus (e.g. does maternal/fetal nutrition have an effect?), when is the key timing that differential methylation occurs in fetal development in order to affect later life traits, what are the most relevant disease-related tissues impacted by the epigenetic mechanism, how does genetic variation at this locus impact these results (though the authors saw no evidence of genetic variants in the DMR affecting their results) and most importantly, how does *CDNK2A/B* transcript expression operate to program body fat throughout the life course?

While there will be more to add to this story, this study demonstrates the importance of using multiple approaches to generate relevant results impacting complex disease. Biomedical research needs to continue to combine fundamental approaches and findings in ways that move us towards mechanistic insights and eventually translate research findings into clinical applications.
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